Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DE vs GSK✓SelectedUSD · GSKDE vs GSK performance historyLatest closeAs of-0.73%11/17
Stock and ETF performance explorer

DE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+723.7%
GSK return
+104.0%
Excess return
+619.7%
Maximum drawdown
-37.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-2.3%+1.6%0.0%
7D-5.6%-3.0%-2.6%-4.7%
30D+1.1%+0.4%+0.8%+0.9%
3M+8.5%-1.2%+9.7%+8.5%
6M+16.1%+0.9%+15.2%+15.0%
YTD+40.6%+4.0%+36.6%+37.6%
1Y+38.0%+7.3%+30.7%+33.6%
3Y+75.9%+57.1%+18.8%+44.5%
5Y+96.0%+43.0%+53.1%+63.4%
10Y+723.7%+103.1%+620.6%+489.4%
All+723.7%+104.0%+619.7%+489.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling